High Dose-Rate Brachytherapy Afterloader Supplied to Leading Cancer Hospital in China
By MedImaging International staff writers Posted on 31 Mar 2011 |
Cancer patients in China will gain access to cutting edge cancer care with the announcement that a leading cancer center is acquiring a brachytherapy afterloader.
The GammaMed device is the first high dose-rate afterloader supplied to Chinese hospitals by Varian Medical Systems, Inc. (Palo Alto, CA, USA), a world leader in radiotherapy systems. Jilin University No. 1 Hospital (Jilin, China) will shortly begin offering treatments using the new equipment, which was ordered in late December 2010 and installed in mid-February 2011. The hospital is the leading oncology center in Jilin province, in the northeast of China.
Brachytherapy treats cancer by placing radioactive sources directly into or next to the area requiring treatment, enabling clinicians to deliver a high dose with minimal impact on surrounding healthy tissues. Brachytherapy has been employed in the treatment of tumors of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck, as well as soft tissue sarcomas and several other types of cancer.
Clinicians at Jilin reported that early brachytherapy treatments would focus on cervical and rectal cancers. The decision to install Varian machines was based on the company's reputation for advanced systems and excellent service, as well as a desire to integrate the hospital's brachytherapy offering with its external beam systems, which are also supplied by Varian Medical Systems. Deng Fei, Varian's sales manager in China, said, "Jilin University No. 1 Hospital is striving for an integrated clinical environment based on one of the most advanced technologies available.”
Tom Duffy, Varian's head of oncology systems business in Asia, said, "Varian brings its expertise as the world leader in external beam radiotherapy to its brachytherapy offerings, which we are now licensed to sell in China. Brachytherapy is a clinically proven way of placing high dose within the tumor, and computer-controlled afterloaders allow this process to be undertaken in a precise and efficient manner. We are pleased to be working with this leading cancer center to bring Varian's brachytherapy treatment systems to China.”
Related Links:
Varian Medical Systems
The GammaMed device is the first high dose-rate afterloader supplied to Chinese hospitals by Varian Medical Systems, Inc. (Palo Alto, CA, USA), a world leader in radiotherapy systems. Jilin University No. 1 Hospital (Jilin, China) will shortly begin offering treatments using the new equipment, which was ordered in late December 2010 and installed in mid-February 2011. The hospital is the leading oncology center in Jilin province, in the northeast of China.
Brachytherapy treats cancer by placing radioactive sources directly into or next to the area requiring treatment, enabling clinicians to deliver a high dose with minimal impact on surrounding healthy tissues. Brachytherapy has been employed in the treatment of tumors of the prostate, cervix, endometrium, breast, skin, bronchus, esophagus, and head and neck, as well as soft tissue sarcomas and several other types of cancer.
Clinicians at Jilin reported that early brachytherapy treatments would focus on cervical and rectal cancers. The decision to install Varian machines was based on the company's reputation for advanced systems and excellent service, as well as a desire to integrate the hospital's brachytherapy offering with its external beam systems, which are also supplied by Varian Medical Systems. Deng Fei, Varian's sales manager in China, said, "Jilin University No. 1 Hospital is striving for an integrated clinical environment based on one of the most advanced technologies available.”
Tom Duffy, Varian's head of oncology systems business in Asia, said, "Varian brings its expertise as the world leader in external beam radiotherapy to its brachytherapy offerings, which we are now licensed to sell in China. Brachytherapy is a clinically proven way of placing high dose within the tumor, and computer-controlled afterloaders allow this process to be undertaken in a precise and efficient manner. We are pleased to be working with this leading cancer center to bring Varian's brachytherapy treatment systems to China.”
Related Links:
Varian Medical Systems
Latest Nuclear Medicine News
- Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
- Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
- Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
- Innovative PET Imaging Technique to Help Diagnose Neurodegeneration
- New Molecular Imaging Test to Improve Lung Cancer Diagnosis
- Novel PET Technique Visualizes Spinal Cord Injuries to Predict Recovery
- Next-Gen Tau Radiotracers Outperform FDA-Approved Imaging Agents in Detecting Alzheimer’s
- Breakthrough Method Detects Inflammation in Body Using PET Imaging
- Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients
- Combining Advanced Imaging Technologies Offers Breakthrough in Glioblastoma Treatment
- New Molecular Imaging Agent Accurately Identifies Crucial Cancer Biomarker
- New Scans Light Up Aggressive Tumors for Better Treatment
- AI Stroke Brain Scan Readings Twice as Accurate as Current Method
- AI Analysis of PET/CT Images Predicts Side Effects of Immunotherapy in Lung Cancer
- New Imaging Agent to Drive Step-Change for Brain Cancer Imaging
- Portable PET Scanner to Detect Earliest Stages of Alzheimer’s Disease
Channels
Radiography
view channel
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreMRI
view channel
Cutting-Edge MRI Technology to Revolutionize Diagnosis of Common Heart Problem
Aortic stenosis is a common and potentially life-threatening heart condition. It occurs when the aortic valve, which regulates blood flow from the heart to the rest of the body, becomes stiff and narrow.... Read more
New MRI Technique Reveals True Heart Age to Prevent Attacks and Strokes
Heart disease remains one of the leading causes of death worldwide. Individuals with conditions such as diabetes or obesity often experience accelerated aging of their hearts, sometimes by decades.... Read more
AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans
Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more
AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans
Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read moreUltrasound
view channel.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read more
AI Identifies Heart Valve Disease from Common Imaging Test
Tricuspid regurgitation is a condition where the heart's tricuspid valve does not close completely during contraction, leading to backward blood flow, which can result in heart failure. A new artificial... Read moreGeneral/Advanced Imaging
view channel
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read more
CT-Based Deep Learning-Driven Tool to Enhance Liver Cancer Diagnosis
Medical imaging, such as computed tomography (CT) scans, plays a crucial role in oncology, offering essential data for cancer detection, treatment planning, and monitoring of response to therapies.... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more